Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine-Ketamine vs Ketamine for Anesthesia Induction in Septic Shock
NCT03844984Phase 3Completed
- Sponsor
- Cairo University
- Start
- Feb 2019
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of lidocaine in septic shock, sponsored by Cairo University. Primary endpoint: Mean arterial blood pressure at 10 minutes. Started Feb 2019; status: completed.
02
Drugs
lidocaine
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT03844984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03844984.